Skip to main content
. 2017 Dec 12;12(12):e0189488. doi: 10.1371/journal.pone.0189488

Fig 2. Results of pp65- and IE-1 specific ELISPOT at pretransplant, post-transplant 1 month, and post-transplant 3 months in recipients with post-KT CMV DNAemia (-) and CMV DNAemia (+) by Mann-Whitney U test.

Fig 2

(A) For pp65-ELISPOT, patients with CMV DNAemia (+) had significantly lower response at post-transplant 1 month than patients with CMV DNAemia (-) [median (95% CI): 8.5 (1.4–130.5) vs. 138.0 (87.2–214.7), P = 0.016]. (B) For IE-1-ELISPOT, CMV DNAemia (+) patients showed significantly lower response at post-transplant 1 and 3 months compared to CMV DNAemia (-) patients (4.0 (1.0–8.1) vs. 18.0 (8.0–44.0), P = 0.019 and 2.0 (0.0–46.6) vs. 27.0 (13.0–56.4), P = 0.014, respectively).